ImageneBio, Inc.

IMANasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$800,000

▼ 77.1% YoY

Net Income

-$45.3M

▼ 24.0% YoY

EPS

$-9.64

▲ 56.4% YoY

Cash

$94.5M

▲ 680.1% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.